In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Steven Flamm, MD
Professor of Medicine and Surgery
Rush University Medical Center
Research: Madrigal Pharmaceuticals
Tiffany E. Kaiser, PharmD, MS, FCCP
Associate Research Professor of Medicine
Division of Digestive Diseases
University of Cincinnati
Consulting Fees: Eurofins Scientific, Wolters Kluwer (UpToDate)
Other: American College of Clinical Pharmacy
Mazen Noureddin, MD
Houston Research Institute
Advisory Board: Altimmune, BI, BMS, 89BIO, EchoSens, Gilead, GSK, Merck, Novo Nordisk, OWL, Pfizer, Roche diagnostic and Siemens, Terns and Takeda
Principal Investigator for a Drug Study: Allergan, Akero, BMS, Gilead, Galectin, Genfit, Conatus, Corcept, Enanta, Madrigal, Novartis, Novo Nordisk, Shire, Terns, Viking and Zydus
Stockholder: Anaetos, Rivus Pharma, CIMA, ChronWell and Viking
Editorial Board: Gastroenterology
Associate Editor: Clinical Gastroenterology and Hepatology
Federal funding: NIH/NIDDK
- Cindy Davidson has nothing to disclose.
- Libby Lurwick has nothing to disclose.
- John Maeglin has nothing to disclose.
- Kate Nagele has nothing to disclose.
- Jay Runyon has nothing to disclose.